Progyny, Inc. Announces Details for Its Third Quarter 2023
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2023 after the close of the market on Tuesday, November 7, 2023. The company will host a conference...
IPSEN – Buy-back program – Art 5 of MAR – Week 42
Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares *Market (MIC Code)IPSEN549300M6SGDPB4Z94P1116/10/2023FR0010259150258117.59CEUXIPSEN549300M6SGDPB4Z94P1116/10/2023FR00102591501,442117.86XPARIPSEN549300M6SGDPB4Z94P1117/10/2023FR001025915057119.40CEUXIPSEN549300M6SGDPB4Z94P1117/10/2023FR00102591501,502118.56XPARIPSEN549300M6SGDPB4Z94P1118/10/2023FR001025915058118.10AQEUIPSEN549300M6SGDPB4Z94P1118/10/2023FR00102591501,742118.33XPARIPSEN549300M6SGDPB4Z94P1119/10/2023FR00102591504117.10AQEUIPSEN549300M6SGDPB4Z94P1119/10/2023FR001025915044117.10CEUXIPSEN549300M6SGDPB4Z94P1119/10/2023FR00102591504117.10TQEXIPSEN549300M6SGDPB4Z94P1119/10/2023FR00102591501,698116.73XPARIPSEN549300M6SGDPB4Z94P1120/10/2023FR001025915056113.76CEUXIPSEN549300M6SGDPB4Z94P1120/10/2023FR00102591501,694113.82XPAR * Two-digit rounding after the decimal TOTAL8,559117.03
...
Retrieve Medical Holdings, Inc. (RMHI) Announces Study
BASKING RIDGE, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (RMHI), the developer of Retrieve Dx™, a real-time, cloud-based CDI (Clinical Documentation Integrity) application that improves physician documentation by alerting physicians to a patient’s comorbidities and additional diagnoses. Today, Retrieve Medical reports the results of a comprehensive study involving 2,530 patients. The physician...
RETIA MEDICAL CLINCHES VICTORY IN VALLETTA, MALTA
Judges from around the world deemed Retia Medical to have had the most novel, market potential and overall impact on healthcare in today's Hemodynamic Market.
WHITE PLAINS, NEW YORK, UNITED STATES, October 24, 2023 /EINPresswire.com/ -- In a thrilling display of healthcare innovation and entrepreneurial prowess, Retia Medical has clinched the prestigious title of Global...
Biostax Announces FINRA Approval for Name and Ticker Symbol
ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today announced a milestone in its transformative rebranding initiative. Both the State of Florida and FINRA have approved its name change from Immune Therapeutics, Inc. to Biostax and is now trading on OTC Pink Markets...
Global Ophthalmic Devices Market Favors Equipment Consolidation, Led by J&J Vision Care, Alcon, and Bausch & Lomb
Continual progress in ophthalmic technology, characterized by enhancements in imaging systems, laser technologies, and surgical equipment, fosters innovation and fuels the expansion of the market.”— Dr. Kamran Zamanian, Senior Partner and CEOVANCOUVER, BC, CANADA, October 24, 2023 /EINPresswire.com/ -- iData Research, a leading global market research firm specializing in medical devices, dental, and pharmaceuticals,...
Global Cell Therapy Manufacturing Market Set to Surge with a CAGR of 14.2% by 2033
FMI Logo
In 2022, the United States held a 42.1% share in North America, and it's projected to maintain its dominant position in the foreseeable future.
NEWARK, DELAWARE, UNITED STATES OF AMERICA, October 24, 2023 /EINPresswire.com/ -- The size of the worldwide cell therapy manufacturing industry is anticipated to grow at a compound annual growth rate...
US Navy Veterans Mesothelioma Advocate Urges the Family of a Navy Submarine Veteran with Mesothelioma to Call for Direct Access to the Nation’s Most Skilled Lawyers-Compensation Might Be Millions-with...
“We want to make finding the most qualified lawyers simple for a Navy Submarine Veteran who now has mesothelioma, and or their family-with our goal the best compensation for the Navy Veteran.”— US Navy Veterans Mesothelioma AdvocateWASHINGTON , DC, USA, October 24, 2023 /EINPresswire.com/ -- According to the US Navy Veterans Mesothelioma Advocate, “We...
Endogena Therapeutics Secures FDA Green Light for
SAN FRANCISCO and TORONTO and ZURICH, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a pioneering biotech company dedicated to revolutionizing regenerative medicine, is proud to announce a significant achievement that holds the promise of transforming lives. The U.S. Food and Drug Administration (FDA) has granted clearance for Endogena's Investigational New Drug (IND) application,...
Mironid appoints Dr Catherine Kelleher as Chief Medical
Mironid appoints Dr Catherine Kelleher as Chief Medical Officer October 24 2023, Glasgow, Scotland – Mironid, a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD), a serious hereditary kidney disease, today announces the appointment of Dr Catherine (Cass) Kelleher as Chief Medical Officer. Dr...
